A phase 2 randomized, double-blind, placebo-controlled trial of PRT064445, a novel, universal antidote for direct and indirect factor Xa inhibitors Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Crowther, Mark
  • Kitt, M
  • Lorenz, T
  • Mathur, V
  • Lu, G
  • Hutchaleelaha, A
  • Hollenbach, S
  • Curnutte, J
  • Becker, RC

publication date

  • July 1, 2013